Testosterone (low-dose, female-physiologic)

What it is

Women produce testosterone throughout life. Levels peak in the mid-20s and decline gradually thereafter, with a steeper drop after natural or surgical menopause.

Female-physiologic dosing aims to restore testosterone to the upper end of the premenopausal normal range — never above it. This is fundamentally different from male testosterone replacement.

How it works

Restoring physiologic testosterone supports sexual desire, arousal, and overall sexual satisfaction. Many patients also report improved energy, mood, and cognitive sharpness.

Treatment is monitored with follow-up labs at 6-8 weeks to confirm dosing is in the therapeutic range.

Who it's for

• Postmenopausal women with bothersome low libido, particularly already stable on estrogen
• Women who have had surgical menopause (oophorectomy)
• Carefully selected perimenopausal women on a case-by-case basis

Who should not take it

• Pregnancy or possible pregnancy
• Hormone-sensitive cancers
• Patients unwilling to do follow-up labs

Common side effects

• Acne or oily skin (uncommon at physiologic dosing)
• Mild hair changes
• Voice changes only at supraphysiologic dosing — which is why monitoring matters

Evidence summary

• 2019 Global Consensus Position Statement supports testosterone for hypoactive sexual desire disorder in postmenopausal women.
• Multiple RCTs show improvement in sexual desire, arousal, and orgasm with appropriate dosing.

FAQ

Sources

• 2019 Global Consensus Position Statement on Testosterone Therapy for Women
• NAMS 2022 Hormone Therapy Position Statement
• ACOG: Menopausal Symptom Management

Symptoms Testosterone (low-dose, female-physiologic) can help treat

Other medications

This page is educational and is not a substitute for a clinical evaluation. Whether any medication is appropriate for you depends on your full medical history. Kindr providers make individualized prescribing decisions during a clinical visit.